
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $430.8M | $888.6M | $2.5B | $1.2B | $851.4M | |
Revenue Growth (YoY) | -20.86% | 106.24% | 178.31% | -53.14% | -26.54% | |
Cost of Revenues | $254.6M | $688.1M | $2.2B | $860.9M | $542.3M | |
Gross Profit | $176.2M | $200.4M | $259.7M | $298.1M | $309.1M | |
Gross Profit Margin | 40.9% | 22.55% | 10.5% | 25.72% | 36.31% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $42.9M | $47.1M | $66.1M | $87.5M | $94.1M | |
Other Inc / (Exp) | $3M | -$10.1M | -$25.7M | $16.5M | $25.2M | |
Operating Expenses | $42.9M | $47.1M | $66.1M | $87.5M | $94.1M | |
Operating Income | $133.3M | $153.3M | $193.6M | $210.6M | $215M | |
Net Interest Expenses | $89.4M | $80.8M | $59.5M | $67M | $61M | |
EBT. Incl. Unusual Items | $46.8M | $62.4M | $108.3M | $160.1M | $179.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $13.9M | $21.2M | $28.3M | $33.2M | $26.1M | |
Net Income to Company | $32.9M | $41.2M | $80M | $126.8M | $153M | |
Minority Interest in Earnings | $5.9M | -$71K | -$53.7M | -$96.4M | -$120.2M | |
Net Income to Common Excl Extra Items | $38.8M | $41.1M | $26.3M | $30.4M | $32.9M | |
Basic EPS (Cont. Ops) | -- | -- | $0.51 | $1.16 | $1.29 | |
Diluted EPS (Cont. Ops) | -- | -- | $0.51 | $1.11 | $1.27 | |
Weighted Average Basic Share | $23.9M | $24.4M | $26.3M | $26.3M | $25.4M | |
Weighted Average Diluted Share | $23.9M | $24.4M | $26.3M | $108.3M | $25.8M | |
EBITDA | $252.8M | $271.6M | $296.9M | $356.1M | $341.1M | |
EBIT | $136.3M | $143.2M | $167.9M | $227.1M | $240.2M | |
Revenue (Reported) | $430.8M | $888.6M | $2.5B | $1.2B | $851.4M | |
Operating Income (Reported) | $133.3M | $153.3M | $193.6M | $210.6M | $215M | |
Operating Income (Adjusted) | $136.3M | $143.2M | $167.9M | $227.1M | $240.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $164.8M | $591.7M | $211.1M | $200.1M | $315.1M | |
Revenue Growth (YoY) | -- | 259% | -64.33% | -5.19% | 57.46% | |
Cost of Revenues | $88.7M | $537.2M | $139.2M | $133.4M | $224.3M | |
Gross Profit | $76.2M | $54.5M | $71.9M | $66.7M | $90.8M | |
Gross Profit Margin | 46.21% | 9.21% | 34.06% | 33.34% | 28.8% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $13.3M | $12.6M | $22.3M | $21.6M | $21.4M | |
Other Inc / (Exp) | $561K | -$6.1M | $4.3M | $5.5M | $6.8M | |
Operating Expenses | $13.3M | $12.6M | $22.3M | $21.6M | $25M | |
Operating Income | $62.8M | $41.9M | $49.6M | $45.2M | $65.7M | |
Net Interest Expenses | $20.8M | $19.2M | $15.5M | $15.6M | $14.3M | |
EBT. Incl. Unusual Items | $42.5M | $16.6M | $38.3M | $35M | $58.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $4.5M | $3.7M | $7.6M | $6.9M | $6M | |
Net Income to Company | $38M | $12.8M | $30.7M | $28.1M | $52.1M | |
Minority Interest in Earnings | $1.2M | $1.1M | -$23.9M | -$21.8M | -$3.2M | |
Net Income to Common Excl Extra Items | $39.3M | $13.9M | $6.8M | $6.3M | $49M | |
Basic EPS (Cont. Ops) | $1.76 | -- | $0.26 | $0.24 | $0.48 | |
Diluted EPS (Cont. Ops) | $1.76 | -- | $0.26 | $0.24 | $0.46 | |
Weighted Average Basic Share | $22.3M | $24.4M | $26.3M | $26.2M | $23.9M | |
Weighted Average Diluted Share | $22.3M | $24.4M | $26.3M | $26.2M | $106.8M | |
EBITDA | $95.1M | $67.2M | $86.5M | $74M | $94.5M | |
EBIT | $63.4M | $35.8M | $53.9M | $50.6M | $72.5M | |
Revenue (Reported) | $164.8M | $591.7M | $211.1M | $200.1M | $315.1M | |
Operating Income (Reported) | $62.8M | $41.9M | $49.6M | $45.2M | $65.7M | |
Operating Income (Adjusted) | $63.4M | $35.8M | $53.9M | $50.6M | $72.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $1.3B | $2.1B | $1.1B | $966.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | $1.1B | $1.8B | $855.1M | $633.2M | |
Gross Profit | -- | $178.8M | $277.1M | $292.9M | $333.2M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | $46.4M | $75.8M | $86.7M | $93.9M | |
Other Inc / (Exp) | $829K | -$16.8M | -$15.3M | $17.6M | $26.4M | |
Operating Expenses | -- | $46.4M | $75.8M | $86.7M | $97.6M | |
Operating Income | -- | $132.4M | $201.3M | $206.2M | $235.6M | |
Net Interest Expenses | $42.2M | $79.2M | $55.9M | $67.1M | $59.7M | |
EBT. Incl. Unusual Items | -- | $36.4M | $130.1M | $156.8M | $202.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | $20.4M | $32.2M | $32.5M | $25.2M | |
Net Income to Company | -- | $16M | $97.9M | $124.2M | $177M | |
Minority Interest in Earnings | $2.3M | -$254K | -$78.7M | -$94.4M | -$101.5M | |
Net Income to Common Excl Extra Items | -- | $15.8M | $19.2M | $29.9M | $75.5M | |
Basic EPS (Cont. Ops) | -- | -- | $0.77 | $1.14 | $1.56 | |
Diluted EPS (Cont. Ops) | -- | -- | $0.77 | $1.01 | $1.47 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | $243.6M | $316.2M | $343.5M | $361.6M | |
EBIT | -- | $115.6M | $186M | $223.8M | $262M | |
Revenue (Reported) | -- | $1.3B | $2.1B | $1.1B | $966.4M | |
Operating Income (Reported) | -- | $132.4M | $201.3M | $206.2M | $235.6M | |
Operating Income (Adjusted) | -- | $115.6M | $186M | $223.8M | $262M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $164.8M | $591.7M | $211.1M | $200.1M | $315.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $88.7M | $537.2M | $139.2M | $133.4M | $224.3M | |
Gross Profit | $76.2M | $54.5M | $71.9M | $66.7M | $90.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $13.3M | $12.6M | $22.3M | $21.6M | $21.4M | |
Other Inc / (Exp) | $561K | -$6.1M | $4.3M | $5.5M | $6.8M | |
Operating Expenses | $13.3M | $12.6M | $22.3M | $21.6M | $25M | |
Operating Income | $62.8M | $41.9M | $49.6M | $45.2M | $65.7M | |
Net Interest Expenses | $20.8M | $19.2M | $15.5M | $15.6M | $14.3M | |
EBT. Incl. Unusual Items | $42.5M | $16.6M | $38.3M | $35M | $58.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $4.5M | $3.7M | $7.6M | $6.9M | $6M | |
Net Income to Company | $38M | $12.8M | $30.7M | $28.1M | $52.1M | |
Minority Interest in Earnings | $1.2M | $1.1M | -$23.9M | -$21.8M | -$3.2M | |
Net Income to Common Excl Extra Items | $39.3M | $13.9M | $6.8M | $6.3M | $49M | |
Basic EPS (Cont. Ops) | $1.76 | -- | $0.26 | $0.24 | $0.48 | |
Diluted EPS (Cont. Ops) | $1.76 | -- | $0.26 | $0.24 | $0.46 | |
Weighted Average Basic Share | $22.3M | $24.4M | $26.3M | $26.2M | $23.9M | |
Weighted Average Diluted Share | $22.3M | $24.4M | $26.3M | $26.2M | $106.8M | |
EBITDA | $95.1M | $67.2M | $86.5M | $74M | $94.5M | |
EBIT | $63.4M | $35.8M | $53.9M | $50.6M | $72.5M | |
Revenue (Reported) | $164.8M | $591.7M | $211.1M | $200.1M | $315.1M | |
Operating Income (Reported) | $62.8M | $41.9M | $49.6M | $45.2M | $65.7M | |
Operating Income (Adjusted) | $63.4M | $35.8M | $53.9M | $50.6M | $72.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $90.2M | $72.8M | $516.7M | $555.9M | $537.5M | |
Short Term Investments | $10.2M | $12.2M | $13.3M | $16.5M | $43.5M | |
Accounts Receivable, Net | $24.5M | $260.5M | $79.7M | $92.9M | $114.4M | |
Inventory | $22.4M | $105M | $173.6M | $2.9M | $23.9M | |
Prepaid Expenses | $12.4M | $16.2M | $20.8M | $10.3M | $10.5M | |
Other Current Assets | -- | -- | -- | -- | $50.7M | |
Total Current Assets | $167.8M | $490.4M | $823.5M | $699.6M | $754.3M | |
Property Plant And Equipment | $1.6B | $1.5B | $1.5B | $1.6B | $1.6B | |
Long-Term Investments | $441.5M | $435M | $424.1M | $404.8M | $396.1M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | $30.3M | $35M | $45M | $63.2M | $82.4M | |
Total Assets | $2.3B | $2.5B | $2.9B | $2.9B | $2.9B | |
Accounts Payable | $7.1M | $311.6M | $96.8M | $13.8M | $7.1M | |
Accrued Expenses | $49.3M | $67.5M | $55.1M | $82M | $66.9M | |
Current Portion Of Long-Term Debt | $33.9M | $26.1M | $28.6M | $51M | $55.7M | |
Current Portion Of Capital Lease Obligations | $73.9M | $67.7M | $54.4M | $23.8M | $25M | |
Other Current Liabilities | $15.7M | $12.5M | $3.7M | $6.1M | $3.1M | |
Total Current Liabilities | $192.2M | $520.2M | $391.5M | $203.8M | $216.1M | |
Long-Term Debt | $655.7M | $405.6M | $374.2M | $505.1M | $448.7M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.5B | $1.5B | $1.2B | $1.1B | $994.7M | |
Common Stock | -- | -- | $108K | $108K | $108K | |
Other Common Equity Adj | -$15M | -$9.2M | $515K | $505K | $502K | |
Common Equity | $887.1M | $1.1B | $477.4M | $505.4M | $488M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -$116M | -$115.9M | $1.2B | $1.3B | $1.4B | |
Total Equity | $771.2M | $1B | $1.7B | $1.8B | $1.9B | |
Total Liabilities and Equity | $2.3B | $2.5B | $2.9B | $2.9B | $2.9B | |
Cash and Short Terms | $100.5M | $85M | $530M | $572.3M | $581M | |
Total Debt | $689.6M | $431.7M | $402.7M | $556M | $504.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $82.9M | $530.4M | $578.9M | $619.5M | |
Short Term Investments | -- | $12.8M | $13.5M | $18M | $44.4M | |
Accounts Receivable, Net | -- | $127.6M | $53.5M | $60.7M | $79.7M | |
Inventory | -- | $52.2M | $132.2M | $1.1M | $1.1M | |
Prepaid Expenses | -- | $16.2M | $12.4M | $9.5M | $15M | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | -- | $307.2M | $761.9M | $693.6M | $779.8M | |
Property Plant And Equipment | -- | $1.5B | $1.7B | $1.7B | $1.6B | |
Long-Term Investments | -- | $431.9M | $420.2M | $399.2M | $384.9M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | $45.4M | $60.6M | $72.8M | $76M | |
Total Assets | -- | $2.3B | $3B | $2.9B | $2.9B | |
Accounts Payable | -- | $31.5M | $10.7M | $7.3M | $48.3M | |
Accrued Expenses | -- | $81.5M | $49.5M | $85.7M | $69.8M | |
Current Portion Of Long-Term Debt | -- | $27.2M | $28.9M | $52.9M | $56.1M | |
Current Portion Of Capital Lease Obligations | -- | $70.3M | $54M | $24.1M | $25.3M | |
Other Current Liabilities | -- | $8.6M | $3.7M | $6.1M | $3.1M | |
Total Current Liabilities | -- | $250.1M | $310.4M | $196.9M | $233.3M | |
Long-Term Debt | -- | $460.2M | $367.3M | $491.9M | $435.1M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | $1.3B | $1.3B | $1B | $985.7M | |
Common Stock | -- | -- | $108K | $108K | $109K | |
Other Common Equity Adj | -- | -$3.7M | $208K | $1.1M | $90K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -$117M | $1.2B | $1.3B | $1.4B | |
Total Equity | -- | $1B | $1.7B | $1.8B | $1.9B | |
Total Liabilities and Equity | -- | $2.3B | $3B | $2.9B | $2.9B | |
Cash and Short Terms | -- | $95.7M | $544M | $596.9M | $663.9M | |
Total Debt | -- | $487.4M | $396.2M | $544.8M | $491.2M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $32.9M | $41.2M | $80M | $126.8M | $153M | |
Depreciation & Amoritzation | $116.5M | $128.4M | $129M | $129M | $100.9M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$2.5M | -$247.2M | $197.9M | -$21M | -$21.1M | |
Change in Inventories | -$17.1M | -$82.7M | -$68.6M | $169.7M | -- | |
Cash From Operations | $109M | $141.6M | $225.1M | $231.9M | $244.4M | |
Capital Expenditures | $41.3M | $36.1M | $119.3M | $312.7M | $113.3M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$41.3M | -$36.1M | -$119.3M | -$308.6M | -$113.3M | |
Dividends Paid (Ex Special Dividend) | -$7.6M | -- | -$5.4M | -$18.8M | -$25.9M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $62.8M | $118.3M | $794M | $250M | -- | |
Long-Term Debt Repaid | -$92.6M | -$163.1M | -$862.1M | -$115.6M | -$74.2M | |
Repurchase of Common Stock | -- | -- | -- | -- | -$50M | |
Other Financing Activities | $6M | -$79.4M | $2.6M | -$4.3M | $857K | |
Cash From Financing | -$31.4M | -$124.1M | $341.2M | $111.4M | -$149M | |
Beginning Cash (CF) | $73.3M | $109.5M | $91M | $538M | $572.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $36.3M | -$18.6M | $447M | $34.6M | -$17.8M | |
Ending Cash (CF) | $109.5M | $91M | $538M | $572.5M | $554.5M | |
Levered Free Cash Flow | $67.7M | $105.5M | $105.8M | -$80.9M | $131.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $38M | $12.8M | $30.7M | $28.1M | $52.1M | |
Depreciation & Amoritzation | $31.8M | $31.4M | $32.6M | $23.3M | $22M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$12.7M | $144.1M | $24.5M | $30.9M | $33M | |
Change in Inventories | $16.8M | $52.8M | -- | -- | -- | |
Cash From Operations | $47.3M | -$31.4M | $46.8M | $64.7M | $154.8M | |
Capital Expenditures | $5.2M | $11M | $14.9M | $12.8M | $44.1M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$5.2M | -$11M | -$14.9M | -$12.8M | -$44.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$2.7M | -$7.2M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $12.1M | $566.3M | -- | -- | -- | |
Long-Term Debt Repaid | -$20.8M | -$519.1M | -$12.1M | -$16.8M | -$19M | |
Repurchase of Common Stock | -- | -- | -- | -$8.4M | -- | |
Other Financing Activities | -$45M | $6.6M | -$4.2M | $209K | -$1.5M | |
Cash From Financing | -$53.7M | $53.8M | -$16.4M | -$27.7M | -$27.6M | |
Beginning Cash (CF) | $109.5M | $91M | $538M | $572.5M | $554.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -$420K | $35K | $72K | |
Additions / Reductions | -$11.6M | $11.4M | $15.5M | $24.2M | $83M | |
Ending Cash (CF) | $97.9M | $102.4M | $553.1M | $596.7M | $637.6M | |
Levered Free Cash Flow | $42.1M | -$42.4M | $31.9M | $51.9M | $110.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | $16M | $97.9M | $124.2M | $177M | |
Depreciation & Amoritzation | -- | $128.1M | $130.2M | $119.7M | $99.7M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -$90.4M | $78.4M | -$14.7M | -$19M | |
Change in Inventories | -- | -$46.6M | -- | -- | -- | |
Cash From Operations | -- | $63M | $303.2M | $249.7M | $334.6M | |
Capital Expenditures | $5.2M | $41.9M | $123.2M | $310.6M | $144.6M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$41.9M | -$123.2M | -$306.5M | -$144.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$5.4M | -$21.5M | -$30.4M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $672.5M | -- | -- | -- | |
Long-Term Debt Repaid | -- | -$661.4M | -$355.1M | -$120.3M | -$76.3M | |
Repurchase of Common Stock | -- | -- | -- | -$8.4M | -$41.6M | |
Other Financing Activities | -- | -$27.8M | -$8.3M | $204K | -$827K | |
Cash From Financing | -- | -$16.6M | $271M | $100M | -$148.9M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | $4.4M | $451.1M | $43.3M | $41M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | $21M | $180.1M | -$60.8M | $190M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $38M | $12.8M | $30.7M | $28.1M | $52.1M | |
Depreciation & Amoritzation | $31.8M | $31.4M | $32.6M | $23.3M | $22M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$12.7M | $144.1M | $24.5M | $30.9M | $33M | |
Change in Inventories | $16.8M | $52.8M | -- | -- | -- | |
Cash From Operations | $47.3M | -$31.4M | $46.8M | $64.7M | $154.8M | |
Capital Expenditures | $5.2M | $11M | $14.9M | $12.8M | $44.1M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$5.2M | -$11M | -$14.9M | -$12.8M | -$44.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$2.7M | -$7.2M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $12.1M | $566.3M | -- | -- | -- | |
Long-Term Debt Repaid | -$20.8M | -$519.1M | -$12.1M | -$16.8M | -$19M | |
Repurchase of Common Stock | -- | -- | -- | -$8.4M | -- | |
Other Financing Activities | -$45M | $6.6M | -$4.2M | $209K | -$1.5M | |
Cash From Financing | -$53.7M | $53.8M | -$16.4M | -$27.7M | -$27.6M | |
Beginning Cash (CF) | $109.5M | $91M | $538M | $572.5M | $554.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -$420K | $35K | $72K | |
Additions / Reductions | -$11.6M | $11.4M | $15.5M | $24.2M | $83M | |
Ending Cash (CF) | $97.9M | $102.4M | $553.1M | $596.7M | $637.6M | |
Levered Free Cash Flow | $42.1M | -$42.4M | $31.9M | $51.9M | $110.7M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.